Analyst Conference Summaries

Biotechnology Investor Aids

Illumina
ILMN

conference date: January 31, 2017 @ 2:00 PM Pacific Time

Illumina Misses Q1 2016 Preliminary Revenue [April 19, 2016 press release]

Illumina Preliminary Q3 Revenue [Oct. 5, 2015 press release]
Illumina Sequences Profits, Exceeding Q3 Guidance [Oct. 22, 2014]

2017
 
 
 
01/31/2017
 
 
 
2016
02/02/2016
05/03/2016
07/26/2016
11/01/2016
2015
01/27/2015
04/21/2015
07/21/2015
10/20/2015
2014
01/28/2014
04/28/2014
07/23/2014
10/20/2014

Illumina (ILMN) is a manufacturer of DNA analysis equipment.

Illumina web site
Illumina investor relations page


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 BIND
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 HNSN
 INO
 INTC
 ISRG
 JUNO
 MACK
 MCHP
 MDVN
 MYL.
 NVDA
 OPXA
 PLX
 REGN
 SGEN
 XLNX
 XLRN

 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. Before making or terminating an investment you should always verify any factual basis of your decision.

Copyright 2015 William P. Meyers